Vamifeport food effect study in healthy volunteers

Phase 1, randomised, open-label trial of vamifeport (2 arms), sponsored by CSL Limited. Primary endpoints: Area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration, Area under the plasma concentration-time curve from time zero extrapolated to infinity and 1 more. Started May 2025; status: completed.